Addressing PsA GRAPPA Domains With a JAKi

Dr. Schwartzman and Dr. Ruderman discuss the importance of a domain-based approach in PsA management and consider the potential role of a JAK inhibitor. Sponsored by AbbVie Medical Affairs + Health Impact.  https://buff.ly/9gUnxB7